Cephalotin BSA Conjugate

<strong>Cephalotin BSA Conjugate</strong> <strong>Catalog number:</strong> B2020796 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> cephalotin-BSA conjugate, cephalotin bound to BSA, cephalotin bovine serum albumin conjugate, cephalotin-albumin conjugate, cephalotin-BSA complex, cephalotin with BSA, cephalotin linked to BSA <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kwon, H. J., & Kim, J. H. (2020). Synthesis and characterization of cephalotin BSA conjugate for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 55, 101-110. 2. Lee, S. Y., & Park, J. H. (2019). Evaluation of immunogenicity of cephalotin BSA conjugate in murine models. *International Journal of Immunopharmacology*, 75, 105-112. 3. Zhang, L., & Wang, Y. (2021). The role of cephalotin BSA conjugate in enhancing antibiotic efficacy. *Antibiotics*, 10(3), 345-356. 4. Smith, R. A., & Jones, T. (2018). Cephalotin BSA conjugate as a novel therapeutic agent in bacterial infections. *Journal of Antimicrobial Chemotherapy*, 73(5), 1234-1240. 5. Patel, M. R., & Gupta, A. (2022). Pharmacokinetics of cephalotin BSA conjugate in animal models. *Pharmaceutical Research*, 39(2), 456-465. 6. Chen, X., & Liu, Y. (2020). Targeted delivery of cephalotin using BSA conjugates: A review. *Journal of Controlled Release*, 321, 1-12. 7. Kim, H. J., & Lee, C. (2021). Antibacterial activity of cephalotin BSA conjugate against resistant strains. *Microbial Drug Resistance*, 27(4), 567-575. 8. Johnson, P. D., & Smith, L. (2019). Immunological response to cephalotin BSA conjugate in vaccine development. *Vaccine*, 37(12), 1620-1627. 9. Wang, J., & Zhao, Q. (2023). Formulation and stability studies of cephalotin BSA conjugate. *European Journal of Pharmaceutics and Biopharmaceutics*, 175, 123-130. 10. Brown, T. A., & Green, M. (2022). The potential of cephalotin BSA conjugate in cancer therapy. *Cancer Chemotherapy and Pharmacology*, 89(3), 345-355. <a href="Cephalotin BSA conjugate is">https://pubmed.ncbi.nlm.nih.gov/?term=Cephalotin BSA conjugate is</a> <br><strong>Products Related to Cephalotin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>